Evaluation for Possible Infectious Mononucleosis in a 13-Year-Old Female
Initial Laboratory Testing
Begin with a complete blood count with differential and a rapid heterophile antibody test (Monospot) as the most cost-effective initial approach. 1, 2
Complete Blood Count Findings
- Look for lymphocytosis ≥50% of the white blood cell differential and atypical lymphocytosis ≥10% of total lymphocyte count, which strongly support the diagnosis 1, 2
- Absolute lymphocytosis with atypical lymphocytes is present in most cases 3, 4
- Elevated liver enzymes (AST, ALT) occur in approximately 90% of patients and increase clinical suspicion even when heterophile testing is negative 2, 5
Heterophile Antibody Testing
- The Monospot test has 87% sensitivity and 91% specificity and is the most widely used initial diagnostic test 1, 2
- Critical timing consideration: The test usually becomes positive between the sixth and tenth day after symptom onset, so false-negatives are common in the first week of illness 3, 1
- False-negative results occur in approximately 10% of patients overall and are especially common in children younger than 10 years 3, 1
When Heterophile Testing is Negative
If clinical suspicion remains high despite a negative Monospot test, proceed immediately to EBV-specific serologic testing. 3, 1
EBV Serologic Panel
Order the following three antibody tests together 3, 1:
- IgM antibodies to viral capsid antigen (VCA)
- IgG antibodies to VCA
- Antibodies to Epstein-Barr nuclear antigen (EBNA)
Interpretation of EBV Serology
- Acute primary EBV infection: VCA IgM present (with or without VCA IgG) AND EBNA antibodies absent 3, 1, 6
- Past infection (>6 weeks): EBNA antibodies present, which essentially rules out acute mononucleosis as the cause of current symptoms 3, 1
- EBNA antibodies develop 1-2 months after primary infection and persist for life 3
Physical Examination Findings to Document
Focus on these specific clinical features that differentiate EBV mononucleosis 6, 2, 7:
- Posterior cervical lymphadenopathy (highly characteristic of EBV-IM)
- Tonsillar pharyngitis with white exudate or coating
- Periorbital or palpebral edema (occurs in one-third of patients, typically bilateral) 4
- Splenomegaly (present in approximately 50% of cases) 4
- Hepatomegaly (present in approximately 10% of cases) 4
- Temperature elevation (can reach 40°C) 6
Differential Diagnosis Testing
If both heterophile and EBV serologies are negative or equivocal, consider testing for other causes of mononucleosis-like illness 3, 1:
- Cytomegalovirus (CMV) - typically presents with older age, longer symptom duration before presentation, less prominent lymphadenopathy, and less tonsillar involvement 7
- HIV infection - particularly important to consider in adolescents
- Toxoplasma gondii infection
- Adenovirus infection
- Streptococcal pharyngitis (can coexist with EBV-IM)
Critical Pitfalls to Avoid
False-Positive Heterophile Results
Be aware that false-positives can occur in 3:
- Leukemia
- Pancreatic carcinoma
- Viral hepatitis
- CMV infection
Age-Related Testing Considerations
- At 13 years old, this patient is in the typical age range for classic EBV-IM presentation (15-24 years most common, but adolescents 13-14 frequently affected) 2, 4
- Heterophile antibody testing is more reliable in this age group than in younger children 3
Timing of Testing
- Do not rule out mononucleosis based on a single negative heterophile test obtained in the first week of illness 1, 2
- If clinical suspicion is high and initial testing is negative, repeat heterophile testing after 7-10 days or proceed directly to EBV serology 3
Additional Supportive Laboratory Tests
- Liver function tests (AST, ALT, bilirubin) - elevated in 90% of cases and support diagnosis when heterophile is negative
- Abdominal ultrasound if splenomegaly is suspected clinically - helps assess splenic size for activity restriction counseling and differentiates EBV-IM from CMV-IM 7
Special Considerations for This Age Group
- Adolescent females have no increased risk compared to males for severe complications 4
- Screen for complications if symptoms are severe, including neurologic symptoms, severe thrombocytopenia, or respiratory compromise 6, 4
- Counsel regarding activity restriction for 3-8 weeks to prevent splenic rupture, which occurs in 0.1-0.5% of cases and is the most feared complication 2, 4